SS
MXCT icon

SBI Securities’s MaxCyte MXCT Stock Holding History

SBI Securities’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$28 Hold
40
– – ﹤0.01% 3694
2025
Q4 		$62 Hold
40
– – ﹤0.01% 3536
2025
Q3 		$63 Hold
40
– – ﹤0.01% 3644
2025
Q2 		$87 Buy
40
+10
+33% +$24 ﹤0.01% 3580
2025
Q1 		$82 Buy
+30
New +$118 ﹤0.01% 3509

Other funds holding MXCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $641M AUM 61.79% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $88.9M AUM

SBI Securities's MXCT Position: Q1 2026 in Review

SBI Securities held its MaxCyte (MXCT) position steady in Q1 2026 at 40 shares worth $28. The position accounts for ﹤0.01% of the portfolio, ranked #3694.

SBI Securities first reported a position in MXCT in Q1 2025 and has held it in 5 quarters since. The position peaked at $87 in Q2 2025. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.

  • SBI Securities held 40 shares of MaxCyte worth $28 as of Q1 2026.
  • SBI Securities left its MaxCyte share count unchanged in Q1 2026.
  • MaxCyte made up ﹤0.01% of SBI Securities's portfolio in Q1 2026, its #3694 holding.
  • SBI Securities first reported a position in MaxCyte in Q1 2025 and has held it in 5 quarters since.
  • SBI Securities's MaxCyte position peaked at $87 in Q2 2025.
  • 130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.

Based on SBI Securities's 13F filing for Q1 2026, filed 28 Apr 2026.